Prognostic Value of Neutrophil Percentage–Albumin Ratio in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors
Emre Eken, Emel Ayvaz Guneyin, Elif Büyükkurt, Faruk Yıldız et autres
Background: Although immune checkpoint inhibitors (ICIs) have improved survival in advanced melanoma, predicting individual responses remains challenging; thus, practical and inexpensive biomarkers are needed. In this study, we investigated the prognostic value of the neutrophil percentage–albumin ratio (NPAR) in patients with advanced …
tr (code pays fourni par la source)